{"sourcedb":"DevicePMAs@therightstef","sourceid":"P960058_S014","text":"Approval for the clarion(r) multi-strategy cochlear implant hifocus electrode for pediatric use.  The device, as modified, will be marketed under the trade name clarion(r) multi-strategy cochlear implant (pediatric) hifocus electrode and is indicated for severely and profoundly hearing impaired children ages 18-months to 17-years.","project":"consensus_PMA_Age_Indications","denotations":[{"id":"T8","span":{"begin":205,"end":214},"obj":"age_category"},{"id":"T7","span":{"begin":82,"end":91},"obj":"age_category"},{"id":"T6","span":{"begin":326,"end":331},"obj":"age_end_unit"},{"id":"T5","span":{"begin":313,"end":319},"obj":"age_start_unit"},{"id":"T4","span":{"begin":310,"end":312},"obj":"age_start"},{"id":"T3","span":{"begin":323,"end":325},"obj":"age_end"},{"id":"T2","span":{"begin":310,"end":331},"obj":"age_range"},{"id":"T1","span":{"begin":296,"end":304},"obj":"age_category"}]}